A new revolutionary weight loss drug in the making? Novo Nordisk, renowned for Wegovy and Ozempic, has unveiled early trial findings of an oral treatment that could redefine obesity. Join me as we delve into this news, uncover insights about the drug, and explore crucial considerations surrounding the excitement.
Video outline:
0:00 - Introduction
0:11 - Trial Results
0:45 - Unique Combo
1:16 - Safety
1:32 - Market Impact
1:47 - Cautionary Notes
2:07 - Conclusion
Thoughts or topic suggestions? Leave a comment. Thanks for watching!
Disclosure: None. This is not a sponsored video.
Resources:
Study: clinicaltrials.gov/study/NCT0...
www.reuters.com/business/heal...
www.cnbc.com/2024/03/08/novo-...
www.forbes.com/sites/robertha...
Image links:
Novo Nordisk image - www.newsoresund.org
Ozempic image - www.chemist-4-u.com
Disclaimer: These videos are intended for pharmacists. If you’re not a pharmacist and want to learn more about this topic, ask your pharmacist! If you are a pharmacist, always use your own professional judgment and consult any other necessary or appropriate sources prior to making clinical judgments. The information in this video is as current as when it was published. I do not own the rights to any of the images within this video.
#weightloss #obesity #novonordisk #amycretin #wegovy #ozempic #newdrug #heypharmacist
8 июл 2024
